Fox News host and meteorologist Janice Dean said she is taking a break from work to be with her family amid "health issues." ...

Janice Dean explained why she's been missing from 'Fox & Friends' and said she's 'grateful' to supporters 'for the kind words ...

Roche Holding AG said a multiple sclerosis drug showed it could work for most forms of the disease in two late-stage trials, ...

In a new book, Ashley Schneider details her journey of running 125 consecutive marathons across America to raise awareness ...

Aging and shifting hormone levels influence how MS changes over time, and the overlap of these factors during midlife can ...

Fenebrutinib met primary goals in two late-stage trials for the treatment of two different forms of multiple sclerosis.

Roche has reported wins for its BTK inhibitor fenebrutinib in a pair of phase 3 studies across two multiple sclerosis (MS) populations. One victory was based on the finding that the candidate was ...

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...

Roche (OTCQX:RHHBY) shares closed ~4% higher in Europe on Monday as the maker of Ocrevus multiple sclerosis therapy announced ...

A wearable system that measures the brain's electrical activity can show how brain circuits are affected in people with MS, a ...